GPC3 and hepatocellular carcinoma: In particular, GPC3-targeted CAR-T cells were found to eliminate GPC3-positive HCC cells in mice [14] and patient-derived HCC xenograft models [15], further confirming the potential use of GPC3-specific CAR-T cells as a therapy for the treatment of HCC.